The store will not work correctly when cookies are disabled.
(E)-3-(2-hydroxyphenyl)-1-(5-propylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288844
PubChem CID: 6474713
Max Phase: Preclinical
Molecular Formula: C16H16N2O2
Molecular Weight: 268.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCc1cnc(C(=O)/C=C/c2ccccc2O)cn1
Standard InChI: InChI=1S/C16H16N2O2/c1-2-5-13-10-18-14(11-17-13)16(20)9-8-12-6-3-4-7-15(12)19/h3-4,6-11,19H,2,5H2,1H3/b9-8+
Standard InChI Key: LMIDVWCGSFPHHM-CMDGGOBGSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
35.4102 -6.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4091 -7.3488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1171 -7.7577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8268 -7.3483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8239 -6.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1153 -6.1204 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.5301 -6.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2393 -6.5203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5270 -5.2972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.9455 -6.1090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6548 -6.5150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6547 -7.3310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3631 -7.7369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0703 -7.3256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0646 -6.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3556 -6.1020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7010 -7.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7004 -8.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9924 -8.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3489 -5.2849 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
16 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.32 | Molecular Weight (Monoisotopic): 268.1212 | AlogP: 3.03 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.85 | CX Basic pKa: 0.02 | CX LogP: 2.81 | CX LogD: 2.80 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -0.25 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |